publication date: Nov. 9, 2018
Issue 42 - Nov. 9, 2018
To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.
  • Otis Brawley leaves the American Cancer Society as it pursues “open-for-business” strategy amid sliding revenues

    If you walked into your local Long John Silver’s restaurant on Sept. 19 and attempted to “talk like a pirate,” the person behind the counter would give you a free deep-fried Twinkie and prompt you to count out a few coins for the American Cancer Society.

  • Conversation with The Cancer Letter

    Brawley: “I started out talking about black-and-white disparities, and now I write papers talking about state-by-state disparities”

    I wish more Americans would care about other Americans and their health care. I see a certain amount of selfishness sometimes, especially when we start having these arguments about screening.

  • Conversation with The Cancer Letter

    Jaffee: Congressional commitment to NIH will continue through FY2021

    The growing nation’s budget deficit will become a primary focus for many in Congress and President Trump, potentially resulting in calls to cut spending, and thereby effectively capping the rate of growth that the NIH budget has experienced during the past four years. In fact, the president has already called for a 5 percent cut across all departments in FY 2020.

  • An Appreciation

    Arti Hurria, geriatric oncologist at City of Hope, dies in traffic accident

    Arti Hurria, a pioneer of geriatric cancer care at City of Hope, died Nov. 7 in a traffic accident. She was 48.

  • Letter to the Editor

    On behalf of ECOG-ACRIN, we want to add our voices to the condolences for the families and community of those killed in Pittsburgh. We paraphrase the assertion of Edmund Burke that all that is required for evil to triumph is that good people remain silent. In response, as a community dedicated to the relief of suffering, we register our condemnation of this atrocity, and of all those that would prey upon sub-populations of our diverse society.

  • In Brief

    • Richard M. Schulze Family Foundation gives $6 million to Moffitt
    • Paul G. Allen Frontiers Group announces Allen Distinguished Investigators
  • TCCL Logo

  • Clinical Roundup

    • Stereotactic radiosurgery and surgical resection offer similar local control of brain metastases
    • Trisalus pressure-enabled drug delivery increased effect of anti-CEA CAR-T in pancreatic cancer patients with liver metastases
  • Drugs & Targets

    • FDA approves Empliciti + pomalidomide and dexamethasone for multiple myeloma
    • FDA grants Fast Track to selinexor for diffuse large B-cell lymphoma
    • Seattle Genetics submits sBLA for ADCETRIS in frontline treatment of CD30-expressing peripheral T-cell lymphomas
    • BMS, Infinity form collaboration to evaluate Opdivo + IPI-549 in urothelial cancer
    • ASCO, SITC release recommendations for reporting of immuno-oncology clinical trials
    • Sandoz decides not to pursue US biosimilar rituximab
    • FDA’s digital tool seeks to help capture real world data useful in regulatory decision-making
    • Elsevier to integrate NCCN guidelines into Via Oncology

Copyright (c) 2018 The Cancer Letter Inc.